Targeting KRAS in Non-Small Cell Lung Cancer

Kirsten Rat Sarcoma viral oncogene homolog (KRAS) is the most frequently altered oncogene in Non-Small Cell Lung Cancer (NSCLC). KRAS mutant tumors constitute a heterogeneous group of diseases, different from other oncogene-derived tumors in terms of biology and response to treatment, which hinders...

Descripción completa

Detalles Bibliográficos
Autores principales: Corral de la Fuente, Elena, Olmedo Garcia, Maria Eugenia, Gomez Rueda, Ana, Lage, Yolanda, Garrido, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784727/
https://www.ncbi.nlm.nih.gov/pubmed/35083149
http://dx.doi.org/10.3389/fonc.2021.792635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784727/
https://www.ncbi.nlm.nih.gov/pubmed/35083149
http://dx.doi.org/10.3389/fonc.2021.792635

Ejemplares similares